Global Intrauterine Contraceptive Market by Type (Hormonal IUCD, Copper IUCD), By Application (Hospitals, Gynecological Clinics, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Intrauterine Contraceptive Market size is expected to reach USD $1.2 billion by 2028, growing at a CAGR of 5.9% during the forecast period from 2021 to 2028. The key factors driving the growth of this market are rising awareness about unplanned pregnancies and the increasing rate of adoption due to advancements in technology. Rising prevalence rates for infertility are also contributing significantly towards market growth.
Intrauterine Contraceptive (IUDs) are small, contraceptive devices that a doctor inserts into the uterus. They may be referred to as intrauterine contraception or an IUC. Intrauterine Contraceptives (IUCD) is a highly effective form of birth control for women with up to 95% effectiveness in preventing pregnancy and can last between five and twelve years depending on the type. The first IUCD was introduced in the 1970s and has seen major development since then including various shapes, sizes, materials, hormones used, etc. In recent studies, it’s been found that copper-releasing IUDs have very high levels of success when compared to other types which make them popular among doctors around the world.
On the basis of Type, the market is segmented into Hormonal IUCD and Copper IUCD. Copper IUCDs are being used more than hormonal because it has lower side effects such as nausea or acne which are common with women who take estrogen-containing contraceptives.
Hormonal IUCD:
Hormonal IUCD is a type of intrauterine contraceptive, which prevents pregnancy by releasing hormones into the uterus. Hormonal IUDs are available in different types such as Mirena and Skyla or Liletta and Kyleena. The Hormonal IUDs segment is further bifurcated into Levonorgestrel-releasing Intrauterine System, Depot Medroxyprogesterone Acetate (DMPA)-releasing Intrauterine System and Other.
Copper IUCD:
Copper IUCD is a long-acting, nonhormonal intrauterine device that can be used for birth control. A copper IUD works by releasing small amounts of copper into the uterus which then creates an inflammatory reaction and at the same time releases natural prostaglandin to thicken cervical mucus preventing sperm from fertilizing eggs in parts or fallopian tubes.
The Copper One Intra-Uterine Device (IUCD) has been one of the most popular forms of contraception worldwide since its first introduction in 1988. Its efficacy rates are very high as it provides almost 100% protection against pregnancy while also providing some other benefits such as reduced menstrual cramps, lighter periods, and better general health due to less exposure to hormones.
On the basis of Application, the market is segmented into Hospitals, Gynecological Clinics, Other. There are various types of Intrauterine contraceptives available in hospitals, and they are used for different purposes. The Hospital segment is projected as the largest revenue generator by 2021. Hospitals offer services such as family planning clinics, emergency care centers, or delivery rooms which helps to access IUCDs on time thus having more chances of preventing unwanted pregnancies without any side effects like oral pills.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is expected to dominate the global intrauterine contraceptive market. The rise in awareness about contraceptives and their benefits among women is likely to drive this region's growth in the future.
Europe, Asia Pacific, and Middle East & Africa are also estimated to be growing regions for this market due to an increase in the population of females aged between 15-49 years globally where these segments can find a huge potential for increasing demand for IUCDs.
Growth Factors For The Global Intrauterine Contraceptive Market:
Increasing contraceptive prevalence and population are the prime factors of growth in this market. One of the most important reasons for the use of Intrauterine devices is their efficacy, which can be given from preventing pregnancy with up to 99% effectiveness. In addition, it has fewer side effects as compared to other forms such as oral contraceptives that have a higher risk of getting pregnant again soon after stopping or starting another form.
Up Market Research published a new report titled “Intrauterine Contraceptive Market research report which is segmented by Types (Hormonal IUCD, Copper IUCD), By Applications (Hospitals, Gynecological Clinics, Other), By Players/Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals”.
Report Scope
Report Attributes | Report Details |
Report Title | Intrauterine Contraceptive Market Research Report |
By Type | Hormonal IUCD, Copper IUCD |
By Application | Hospitals, Gynecological Clinics, Other |
By Companies | Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network, Bayer Healthcare, Actavis, Medisafe Distribution, Pace Pharmaceuticals |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 219 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Intrauterine Contraceptive Market Report Segments:
The market is segmented by Type Hormonal IUCD, Copper IUCD and By Application Hospitals, Gynecological Clinics, Other.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Medicines360
- Trimedic Supply Network
- Bayer Healthcare
- Actavis
- Medisafe Distribution
- Pace Pharmaceuticals
Intrauterine Contraceptive Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Intrauterine Contraceptive Market
Overview of the regional outlook of the Intrauterine Contraceptive Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Intrauterine Contraceptive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Intrauterine Contraceptive Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Hormonal IUCD
2. Copper IUCD
7. By Application:1. Hospitals
2. Gynecological Clinics
3. Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Intrauterine Contraceptive Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrauterine Contraceptive Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrauterine Contraceptive Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrauterine Contraceptive Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrauterine Contraceptive Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrauterine Contraceptive Market Size & Forecast, 2018-2028
4.5.1 Intrauterine Contraceptive Market Size and Y-o-Y Growth
4.5.2 Intrauterine Contraceptive Market Absolute $ Opportunity
Chapter 5 Global Intrauterine Contraceptive Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Intrauterine Contraceptive Market Size Forecast by Type
5.2.1 Hormonal IUCD
5.2.2 Copper IUCD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Intrauterine Contraceptive Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Intrauterine Contraceptive Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Gynecological Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrauterine Contraceptive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrauterine Contraceptive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Intrauterine Contraceptive Analysis and Forecast
9.1 Introduction
9.2 North America Intrauterine Contraceptive Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Intrauterine Contraceptive Market Size Forecast by Type
9.6.1 Hormonal IUCD
9.6.2 Copper IUCD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Intrauterine Contraceptive Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Gynecological Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Intrauterine Contraceptive Analysis and Forecast
10.1 Introduction
10.2 Europe Intrauterine Contraceptive Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Intrauterine Contraceptive Market Size Forecast by Type
10.6.1 Hormonal IUCD
10.6.2 Copper IUCD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Intrauterine Contraceptive Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Gynecological Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Intrauterine Contraceptive Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Type
11.6.1 Hormonal IUCD
11.6.2 Copper IUCD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Intrauterine Contraceptive Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Gynecological Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Intrauterine Contraceptive Analysis and Forecast
12.1 Introduction
12.2 Latin America Intrauterine Contraceptive Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Intrauterine Contraceptive Market Size Forecast by Type
12.6.1 Hormonal IUCD
12.6.2 Copper IUCD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Intrauterine Contraceptive Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Gynecological Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Intrauterine Contraceptive Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Type
13.6.1 Hormonal IUCD
13.6.2 Copper IUCD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Intrauterine Contraceptive Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Gynecological Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrauterine Contraceptive Market: Competitive Dashboard
14.2 Global Intrauterine Contraceptive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceutical Industries
14.3.2 Medicines360
14.3.3 Trimedic Supply Network
14.3.4 Bayer Healthcare
14.3.5 Actavis
14.3.6 Medisafe Distribution
14.3.7 Pace Pharmaceuticals